$ABEV earnings report

Ambev reported 3Q26 organic net revenue growth of 7.6% and organic Normalized EBITDA growth of 8.9%, while consolidated volume rose 0.8% and Normalized EBITDA margin expanded 40 bps to 33.7%. AlphAI read Ambev's Q3 FY2026 filing as solid.

Q3 FY2026

AlphAI · Earnings readABEV · Q3 2026 · ended September 30, 2026

Ambev reported 3Q26 organic net revenue growth of 7.6% and organic Normalized EBITDA growth of 8.9%, while consolidated volume rose 0.8% and Normalized EBITDA margin expanded 40 bps to 33.7%.

✓Solid quarter

Organic revenue, Normalized EBITDA and Normalized Profit grew, supported by pricing, mix and margin expansion across all business units. Volume growth remained modest, with declines in Canada and LAS, while reported profit declined because of exceptional-item comparisons and higher income tax expense.

Revenue
R$21.6B
7.6% organic y/y
Brazil Beer
R$10.1B
4.8% organic y/y
Gross margin · other
51.0%
60 bps organic y/y
EPS · non-GAAP
0.28
15.4% y/y

Key metrics

shortened, hover for the filing’s print
MetricValueq/qy/y
3Q26 Volume ('000 hl)other42,385.0–0.8% organic
3Q26 Net revenueotherR$21.59B–7.6% organic
3Q26 Net revenue/hlotherR$ 509.5–6.8% organic
3Q26 Gross profitotherR$11.01B–8.9% organic
3Q26 Gross marginother51.0%–60 bps organic
3Q26 SG&A excl. deprec. & amort.other−R$5.38B–7.6% organic
3Q26 Normalized Operating Profitnon-GAAPR$5.58B–9.9% organic
3Q26 Normalized EBITDAnon-GAAPR$7.27B–8.9% organic
3Q26 Normalized EBITDA marginnon-GAAP33.7%–40 bps organic
3Q26 Net finance resultsother−R$312.4M–-71.2%
3Q26 Income tax expenseother−R$882.1M–151.9%
3Q26 Effective tax rateother16.8%––
3Q26 ProfitotherR$4.37B–-10.2%
3Q26 Normalized Profitnon-GAAPR$4.39B–14.3%
3Q26 Basic earnings per share (R$)other0.28–-9.5%
3Q26 Diluted earnings per share (R$)other0.27––
3Q26 Normalized basic earnings per share (R$)non-GAAP0.28–15.4%
3Q26 Normalized diluted earnings per share (R$)non-GAAP0.28–15.4%
3Q26 Cash flow from operating activitiesotherR$7.68B–11.0%
YTD26 Volume ('000 hl)other127,080.9–0.7% organic
YTD26 Net revenueotherR$64.21B–7.3% organic
YTD26 Gross profitotherR$33.04B–9.2% organic
YTD26 Gross marginother51.5%–90 bps organic
YTD26 Normalized EBITDAnon-GAAPR$21.20B–9.3% organic
YTD26 Normalized EBITDA marginnon-GAAP33.0%–60 bps organic
YTD26 ProfitotherR$11.73B–2.3%
YTD26 Normalized Profitnon-GAAPR$11.72B–11.6%
YTD26 Cash flow from operating activitiesotherR$15.55B––

Segments

SegmentRevenueq/qy/y
Brazil BeerVolumes grew 0.5%, while net revenue per hectoliter excluding marketplace increased by 4.8%, driven mainly by revenue management and portfolio mix.R$10.14B–4.8% organic
Brazil NABVolumes increased by 3.6% and NR/hl increased by 2.6%, reflecting revenue management and favorable brand mix.R$2.21B–6.3% organic
Central America and the Caribbean (CAC)Total volumes increased by 2.3%, with beer volumes outperforming, and NR/hl excluding marketplace increased by 6.1%.R$2.57B–8.1% organic
Latin America South (LAS)Volumes declined by 1.4%, while NR/hl excluding marketplace grew 23.6%, led by consistent revenue management.R$4.04B–21.4% organic
CanadaVolumes decreased by 1.0% in a soft industry, while NR/hl excluding marketplace grew by 2.2% through revenue management and premiumization.R$2.64B–1.2% organic

FY26 outlook

  • NoteBrazil Beer Cash COGS/hl, excluding the sale of non-Ambev products on the marketplace, expected to increase between 4.5% and 7.5%.

Capital returns

  • On October 28th, 2026, the Board of Directors approved a Share Buyback Program for up to 190,000,000 common shares.
  • The repurchase limit corresponds to R$ 2.9 billion, based on the closing share price of October 28th, 2026.
  • The Program will remain in effect until April 28, 2028.
  • Proceeds from/(buybacks of) treasury shares were R$ (680.4) million in 3Q26 and R$ (3,333.0) million in YTD26.
  • Dividends and interest on capital paid were R$ (1,377.2) million in 3Q26 and R$ (2,561.7) million in YTD26.

What drove it

  • Consolidated NR/hl grew 6.8% organically and consolidated volume grew 0.8% organically.
  • Premium brands delivered mid-teens volume growth, Balanced Choices grew by low nineties, and no-alcohol beer grew by low thirties.
  • BEES Marketplace GMV grew approximately 57%, supported mainly by continued third-party partnership expansion.
  • Zé GMV grew approximately 16%, supported by a 12% increase in monthly buyers.
  • Cash COGS/hl excluding marketplace increased by 6.5%, while gross margin expanded 60 bps through productivity and operational-efficiency initiatives.
  • Normalized EBITDA grew in all business units.

Concerns

  • Canada volume decreased by 1.0% amid softer consumer demand.
  • LAS volume decreased by 1.4%; Argentina total volumes declined by mid-single digit, mostly impacted by adverse weather and a soft consumer environment.
  • Brazil Beer Normalized EBITDA margin contracted 130 bps organically to 34.9%.
  • Cash SG&A increased by 7.6%, mainly due to incremental sales and marketing investments and higher distribution expenses.
  • Income tax expense increased to R$ (882.1) million from R$ (350.2) million, and the effective tax rate increased to 16.8% from 6.7%.
  • 3Q26 Profit declined 10.2% to R$ 4,366.3 million despite Normalized Profit growth.

What to watch

  • Brazil Beer Cash COGS/hl guidance of an increase between 4.5% and 7.5% for FY26.
  • The durability of Brazil Beer volume recovery and market-share gains following FIFA World Cup-related timing effects.
  • Volume trends in Canada and LAS, particularly consumer demand in Argentina.
  • The pace of premium, Balanced Choices, no-alcohol and beyond-beer portfolio growth.
  • Execution of the buyback program through April 28, 2028.
  • The impact of Argentina hyperinflation accounting and the FY26 organic revenue growth cap of 2% per month in Argentina.

Balance sheet and cash flow

  • Cash and cash equivalents less bank overdrafts were R$ 19,188.2 million at September 30, 2026, versus R$ 18,638.2 million at December 31, 2025.
  • Current investment securities were R$ 2,725.9 million at September 30, 2026, versus R$ 1,681.7 million at December 31, 2025.
  • Consolidated Debt was R$ 2,714.8 million at September 30, 2026, versus R$ 3,386.9 million at December 31, 2025.
  • Net debt/(cash) was R$ (19,199.4) million at September 30, 2026, versus R$ (16,933.0) million at December 31, 2025.
  • Cash flow from operating activities was R$ 7,677.9 million in 3Q26, versus R$ 6,919.0 million in 3Q25.
  • Cash flow from/(used in) investing activities was R$ (2,083.7) million in 3Q26, including acquisitions of property, plant and equipment and intangible assets of R$ (1,133.0) million.
  • Cash flow from/(used in) financing activities was R$ (3,016.7) million in 3Q26.
  • Cash and cash equivalents at the end of the period were R$ 19,188.2 million.

Analysis

Ambev delivered 3Q26 organic net revenue growth of 7.6% on 0.8% organic volume growth, with pricing and mix the principal top-line contributors. Consolidated NR/hl increased 6.8% organically. Brazil NAB, CAC and Brazil Beer produced volume growth, while Canada and LAS declined. LAS generated the fastest revenue growth at 21.4% organically despite a 1.4% volume decline, illustrating the importance of revenue management in the quarter.

Underlying profitability improved. Normalized EBITDA increased 8.9% organically to R$ 7,270.9 million and Normalized EBITDA margin expanded 40 bps organically to 33.7%. Gross margin expanded 60 bps organically even as cash COGS/hl excluding marketplace increased 6.5%. CAC and LAS were major margin contributors, with organic Normalized EBITDA growth of 11.4% and 41.5%, respectively. Brazil Beer remained positive at 1.0% organic Normalized EBITDA growth, but its Normalized EBITDA margin contracted 130 bps.

Reported earnings presented a different picture from normalized earnings. Profit fell 10.2% to R$ 4,366.3 million, while Normalized Profit rose 14.3% to R$ 4,393.6 million and Normalized EPS increased 15.4% to R$ 0.28. The release attributes normalized-profit growth primarily to EBITDA growth and lower net financial expenses, partly offset by higher income tax expenses. Net finance results improved to R$ (312.4) million from R$ (1,086.0) million, but income tax expense increased to R$ (882.1) million and the effective tax rate rose to 16.8%.

Cash generation strengthened, with cash flow from operating activities increasing 11.0% to R$ 7,677.9 million, supported by EBITDA growth and working-capital dynamics. At September 30, 2026, the company reported R$ (19,199.4) million of net debt/(cash). Capital allocation included R$ (680.4) million of treasury-share buybacks in the quarter and approval of a new program for up to 190,000,000 common shares through April 28, 2028.

Management maintained FY26 Brazil Beer Cash COGS/hl guidance, excluding non-Ambev marketplace products, for an increase between 4.5% and 7.5%. The near-term operating focus is on sustaining NR/hl growth ahead of cost inflation while restoring volume momentum in Canada and LAS. The release also highlights Argentina reporting complexity: FY26 organic revenue growth uses a price-growth cap of 2% per month when triggered, and Argentine operations remain subject to IAS 29 hyperinflation accounting.

Management, verbatim

The third quarter built on the progress we achieved in the first half of the year, with the consistent execution of our strategy delivering growth in volumes, net revenue and Normalized EBITDA, alongside margin expansion

Carlos Lisboa, CEO

Not in the filing

stated, not guessed
  • Previous-release outlook was not provided, so no comparison with prior guidance is available.
  • Free cash flow was not reported.
  • A consolidated operating cash flow margin was not reported.
  • No forward revenue, gross-margin, operating-expense or tax-rate guidance was reported.
  • Prior-quarter values for the reported 3Q26 key metrics were not reported.

Written by an AI language model from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure is checked against the filing text, and a metric the filing does not print, or whose value, prior period and change do not add up, is dropped from the metrics. The model can still misread a table, in the metrics or in the text, so check a number in the filing before you rely on it. Consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.

Questions about ABEV earnings dates

When is Ambev's next earnings date?
AlphAI has no date for ABEV yet. We do not publish estimates, so this page shows a date the day we have one.
Why is there sometimes no date?
AlphAI leaves out estimates. Many sites fill the gap by adding about 91 days to the last report, but that arithmetic is a guess, and a wrong date costs a reader more than a missing one, so we show nothing until a date is set, and a company can still move it. Every quarter already on this page is read straight from the SEC filing: an 8-K item 2.02 for US filers, a 6-K earnings release for foreign private issuers.